{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-011116","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.219510+00:00","generated_at":"2026-05-15T07:49:26.550762+00:00","sec_items":["1.01","2.02","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aytu BioPharma amends warrants to enable equity classification; expects liability reduction","bullets":["Amended warrants from 2023 and 2025 offerings to clarify stockholder vote cannot change beneficial ownership blockers.","Prior classification as liabilities required recording a liability of $18.1M (Sep 2025) and $25.2M (Dec 2025).","Expects warrant liability reduction and equity increase by the same amount after amendment.","Issued unregistered in reliance on Section 3(a)(9) exchange and Section 4(a)(2) private placement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-011116","json":"https://secwatch.observer/filing/0001437749-26-011116.json","markdown":"https://secwatch.observer/filing/0001437749-26-011116.md","text":"https://secwatch.observer/filing/0001437749-26-011116.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/aytu20260327_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:49:26.550762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"33a1bf6635df3cc3a84a118248bf39690c536109","claim":"AYTU BIOPHARMA, INC amended Amended 2023 Prefunded Warrant with certain institutional investors (effective 2026-03-31).","evidence_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001493152-26-026890","ticker":"XWIN","company_name":"XMax Inc.","filed_at":"2026-06-02T20:30:36+00:00","headline":"XMax raises $3.6M via private placement of 486,500 shares at $7.347/share","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026890","json":"https://secwatch.observer/filing/0001493152-26-026890.json","markdown":"https://secwatch.observer/filing/0001493152-26-026890.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/0001493152-26-026890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/form8-k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"On May 28, 2026, XMax Inc. (the “ Company ”) entered into Securities Purchase Agreements (the “ Agreements ”) with certain non-U.S. investors identified on the signature pages thereto (the “ Purchasers ”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 486,500 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a purchase price of $7.347 per share for an aggregate offering price of $3,574,315.50 (the “ Private Placement ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1473334/000149315226026890/0001493152-26-026890-index.htm"}},{"accession":"0001193125-26-253506","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-06-02T20:10:13+00:00","headline":"Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8","event_type":"other_material","sec_items":["1.01","3.02","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253506","json":"https://secwatch.observer/filing/0001193125-26-253506.json","markdown":"https://secwatch.observer/filing/0001193125-26-253506.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/d95782d8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"On May 26, 2026, the Company entered into a privately negotiated exchange agreement with Streeterville (the “First Exchange Agreement”), pursuant to which the Company issued 31,958 shares (the “First Exchange Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”) to Streeterville in exchange for an aggregate of 3.72 outstanding shares of Series Q Preferred Stock held by Streeterville (the “First Exchanged Preferred Shares”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm"}},{"accession":"0001140361-26-023619","ticker":"GNK","company_name":"GENCO SHIPPING & TRADING LTD","filed_at":"2026-06-02T10:01:31+00:00","headline":"Genco Shipping amends shareholder rights plan, eliminates 'Acting in Concert' definition","event_type":"other_material","sec_items":["1.01","3.03","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-023619","json":"https://secwatch.observer/filing/0001140361-26-023619.json","markdown":"https://secwatch.observer/filing/0001140361-26-023619.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326200/000114036126023619/0001140361-26-023619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326200/000114036126023619/ef20075333_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"On June 2, 2026, Genco Shipping & Trading Limited (the “ Company ”) entered into the Third Amendment to Shareholders Rights Agreement (the “ Third Amendment ”) to amend the Shareholder Rights Agreement, dated as of October 1, 2025 between the Company and Computershare Inc., as amended to date (the “ Rights Agreement ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1326200/000114036126023619/0001140361-26-023619-index.htm"}},{"accession":"0001193125-26-251994","ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-06-01T23:13:20+00:00","headline":"Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251994","json":"https://secwatch.observer/filing/0001193125-26-251994.json","markdown":"https://secwatch.observer/filing/0001193125-26-251994.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526251994/0001193125-26-251994-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526251994/d105562d8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526251994/0001193125-26-251994-index.htm"}},{"accession":"0001683168-26-004423","ticker":"CITR","company_name":"CitroTech Inc.","filed_at":"2026-06-01T20:15:28+00:00","headline":"CitroTech exchanges all Series A Preferred for Series C Convertible; BoltRock gets board rights","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-004423","json":"https://secwatch.observer/filing/0001683168-26-004423.json","markdown":"https://secwatch.observer/filing/0001683168-26-004423.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/894556/000168316826004423/0001683168-26-004423-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894556/000168316826004423/citro_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"On May 28, 2026, CitroTech Inc., a Wyoming corporation (the “Company”), entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/894556/000168316826004423/0001683168-26-004423-index.htm"}},{"accession":"0001500217-26-000035","ticker":"AAT","company_name":"American Assets Trust, Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"AAT board raises Rady Trust ownership cap to 21.9%, lowers general limit to 6.775%","event_type":"other_material","sec_items":["1.01","3.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001500217-26-000035","json":"https://secwatch.observer/filing/0001500217-26-000035.json","markdown":"https://secwatch.observer/filing/0001500217-26-000035.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/0001500217-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/aat-20260511.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"On May 11, 2026, American Assets Trust, Inc. (the \"Company\") entered into a Voting Support Agreement (the \"Voting Agreement\") with the Ernest Rady Trust U/D/T March 10, 1983 (the \"Rady Trust\"), the Evelyn Shirley Rady Trust U/D/T March 10, 1983, and American Assets, Inc. (collectively, the \"Stockholder\").","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/0001500217-26-000035-index.htm"}},{"accession":"0001829126-26-004879","ticker":"SAGU","company_name":"Shreya Acquisition Group","filed_at":"2026-05-11T23:59:59+00:00","headline":"Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004879","json":"https://secwatch.observer/filing/0001829126-26-004879.json","markdown":"https://secwatch.observer/filing/0001829126-26-004879.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/0001829126-26-004879-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/shreyaacq_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"Private Units Subscription Agreement, dated May 6, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2083452/000182912626004879/0001829126-26-004879-index.htm"}},{"accession":"0001193125-26-214698","ticker":"PBT","company_name":"PERMIAN BASIN ROYALTY TRUST","filed_at":"2026-05-08T23:59:59+00:00","headline":"Court approves trust indenture amendments eliminating 75% supermajority requirement","event_type":"other_material","sec_items":["1.01","3.03","5.03","7.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 3.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-214698","json":"https://secwatch.observer/filing/0001193125-26-214698.json","markdown":"https://secwatch.observer/filing/0001193125-26-214698.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/319654/000119312526214698/0001193125-26-214698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/319654/000119312526214698/2026-05_pbt_rslt_of_hear.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (\"Amended 2023 Prefunded Warrant\"), (ii) an Amended and Restated June 2023 Tranche A Warrant (\"Amended 2023 Tranche A Warrant\") and (iii) an Amended and Restated June 2025 Prefunded Warrant (\"Amended 2025 Prefunded Warrant\"), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm","comparable_excerpt":"Argent Trust Company, the trustee of the Trust, entered into Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust dated May 8, 2026 (the “Amendment”) implementing the modifications approved by the Court.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/319654/000119312526214698/0001193125-26-214698-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}